Navigation Links
Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line
Date:7/10/2013

VILNIUS, Lithuania, July 10, 2013 /PRNewswire/ -- Neurotechnology, a provider of high-precision biometric identification technologies, today announced new releases across their entire line of biometric Software Development Kits (SDK), including: MegaMatcher 4.5 multi-biometric SDK for large-scale applications, VeriFinger 6.7 for fingerprint identification, VeriLook 5.4 for facial identification, VeriEye 2.7 for iris identification and VeriSpeak 2.0 for voice identification. The company also announced the addition of facial biometrics to the new MegaMatcher Accelerator 6.0 multi-biometric all-in-one software and hardware solution. Now facial recognition can be used in any combination with fingerprint and iris biometrics for large-scale projects that require high-speed, high-volume identification capabilities.

The new facial biometric capabilities in MegaMatcher Accelerator 6.0 offer fast matching speeds of up to 100 million templates per second and the solution has a capacity of up to 10 million faces on a single server.

MegaMatcher Embedded SDKs are now included in MegaMatcher SDK, which will enable users to develop PC, embedded or mixed biometric systems that support Windows, Linux, Mac OSX and Android platforms. Also, a new component, MegaMatcher Accelerator Development Edition, has been added to the MegaMatcher Extended SDK.

"Faces can now be matched at the same speed level as fingerprints and irises in our flagship product – MegaMatcher Accelerator," said Dr. Justas Kranauskas, project lead for Neurotechnology. "This will significantly reduce the complexity of large-scale identification/de-duplication projects that make use of facial biometrics. We are also hoping to lower the cost of development by adding a Development Edition of MegaMatcher Acce
'/>"/>

SOURCE Neurotechnology
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. NPointer from Neurotechnology Uses Hand Gestures to Control and Navigate Computer Programs Without a Mouse or Touchpad
2. Neurotechnology Launches SkyBiometry Spin-off Company to Deliver SaaS Biometric Identification and Feature Analysis
3. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
4. ChromaDex® Announces Financial Results for the Year Ended 2011
5. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
6. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
7. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
8. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
9. Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
10. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
11. Mass. Eye and Ear announces Curing Kids Fund grant recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)...  Tute Genomics, a leader in cloud-based solutions for ... funding led by UK-based Eurovestech. Peak Ventures and a ... round. "We are at a pivotal time ... and seeks new approaches for the diagnosis, treatment and ... MBA, and CEO of Tute Genomics. "One of the ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
(Date:11/21/2014)... 2014 According to a new ... (Video, RFID, Access Control, Intrusion Detection, Parking Management, Under ... Component Service Geography - Global Forecasts to 2020", published ... to be around $25 Billion in 2014 and is ... a CAGR of 8.69%. Browse 116 market ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... in French . , A single ... is detrimental to the health of the arteries, while no ... fats such as mono-and polyunsaturated fatty acids, according to researchers ... Heart Institute. The Mediterranean meal may even have a positive ...
... up to 17,000 megatonnes of carbon dioxide into the ... by the CGIAR Research Program on Climate Change, Agriculture ... of food production needs to be reduced, a companion ... will require a complete recalibration of where specific crops ...
... to stand up and walk has come closer to reality ... never take another step. , A team of engineers at ... exoskeleton that enables people with severe spinal cord injuries to ... size and modular design promise to provide users with an ...
Cached Biology News:New study reveals that every single junk food meal damages your arteries 2Agriculture & food production contribute up to 29 percent of global greenhouse gas emissions 2Agriculture & food production contribute up to 29 percent of global greenhouse gas emissions 3Agriculture & food production contribute up to 29 percent of global greenhouse gas emissions 4An exoskeleton of advanced design promises a new degree of independence for people with paraplegia 2An exoskeleton of advanced design promises a new degree of independence for people with paraplegia 3An exoskeleton of advanced design promises a new degree of independence for people with paraplegia 4
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, Inc. ... the treatment of chronic pain, announced the results of ... "This was a transformational year in Relmada,s history ... for our company," said Sergio Traversa , chief ... have executed on key financial, human resource and clinical ...
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... San Diego, CA (PRWEB) December 17, 2014 ... strategy and activation agency and member of the Huntsworth ... Jamie Gonzales to its executive team. In her role, ... Services. , “We are incredibly honored to welcome ... said Agency Chief and CEO, Gaëtan Fraikin. “She is ...
(Date:12/17/2014)...   Synageva BioPharma Corp. (NASDAQ: ... rare disorders, announced today its presentation at the upcoming ... San Francisco, CA. Sanj ... present on Monday, January 12, 2015, at 9:00 a.m. ... live and may be accessed from the "Webcasts & ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... 28 , - Guests Will ... , Staying healthy in these stressful ... Attitude Health Retreats early in 2009 may provide,participants with the ... A key component of the retreat ...
... XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , ... it received a Staff Determination Letter (the "Letter") from ... the staff of Nasdaq,s Listing Qualifications Department determined, using ... the Company,s American Depository Shares ("ADRs") would be delisted ...
... web based CTMS (Clinical Trial Management System), has ... deployed visit reports, site payments, sponsor portal and ... project will include integration to our electronic data ... as other innovative functional changes to the system ...
Cached Biology Technology:New Health Retreat Gives a Fresh Attitude Towards Disease Prevention 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 3
Human IL-19 MAb (Clone 152112)...
Mouse Activin RIB/ALK-4 MAb (Clone 207304)...
... Dawbarn and S.J. Allen (1995) ... by world authorities on current issues relating ... disease. Several major advances have been made ... this disease. Topics include molecular neuropathology through ...
... x 29 cm, 1. One system ... of Coomassie Blue or silver-stain gels for ... for high sensitivity ECL detection and chromogenic ... and processing time.Proven design for consistent, high-quality ...
Biology Products: